Compare First Solar, Inc. (FSLR) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Solar, Inc. vs Kymera Therapeutics Inc. Common Stock — how do they compare? First Solar, Inc. trades at $177.11 (market cap $20.05B), while Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B). The key difference: First Solar, Inc. is far larger — about 2.3× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, First Solar, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold First Solar, Inc. for 76 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| FSLR | KYMR | |
|---|---|---|
Market Cap | $20.05B | $8.87B |
Volume | 2,420,017 | 779,107 |
Sector | Energy | Health |
52-Week High | $318.30 | $127.31 |
52-Week Low | $172.11 | $55.80 |
Typical Hold Time | 76 Days | 0 Days |
Enterprise Value | $18.52B | $8.26B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
First Solar (FSLR) trades at $179.08, down 0.36% with bearish technical signals despite strong fundamentals. The stock shows robust revenue growth from $2.6B in 2022 to $5.2B in 2025, with net income margins exceeding 29%. Recent earnings beat expectations in Q1 and Q2 2026, though Q4 2025 missed estimates. Analyst consensus remains positive with a $268.82 price target, while technical indicators show resistance near $181 with oversold RSI conditions.
FSLR presents a value opportunity with attractive valuation multiples (P/E 11.5, P/S 3.73) and strong profitability (ROE 18.51%). Risks include sector-wide pressure from high borrowing costs, patent litigation uncertainties, and recent insider selling. The stock's 35% decline from peaks creates potential upside if solar sector sentiment improves.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About First Solar, Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and a new factory under construction in India.
Read more on FSLR →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
